BCRX 250516 7.00C(BCRX250516C7000) Stock Price Today

US OptionsDetailed Quotes

BCRX250516C7000

Watchlist

1.90
+0.10+5.56%

15min DelayClose May 2 16:00 ET

1.90High1.85Low

Intraday

5D
Daily

News

Earnings Week Ahead: AMD, PLTR, F, DIS, SHOP, DKNG, AMC, LCID, GOLD, RIVN, and More
Seeking Alpha08:00 ET
BioCryst Pharmaceuticals Q1 2025 Earnings Preview
Seeking AlphaMay 2 12:35 ET
Express News | BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersMay 2 07:00 ET
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswireMay 2 07:00 ET
Express News | BioCryst Appoints Steve Frank to Board of Directors
ReutersMay 1 07:00 ET
Press Release: BioCryst Appoints Steve Frank to Board of Directors
Dow JonesMay 1 07:00 ET

Comments

FergusonLeroy

May 1 22:42

$BioCryst Pharmaceuticals (BCRX.US)$ check out lumn stock i think its a good look

Green Bean Sprouting

Feb 28 23:41

$BioCryst Pharmaceuticals (BCRX.US)$
dip = buy！

Teddy123

Feb 24 19:20

BioCryst Announces Positive Results from APeX-P Trial for ORLADEYO® (berotralstat) in Pediatric Patients with Hereditary Angioedema Aged 2 to <12 Years

$BioCryst Pharmaceuticals (BCRX.US)$
Can This Rare Disease Drug Eliminate HAE Attacks in Children? Clinical Trial Says Yes

Green Bean Sprouting

Jan 21 22:52

$BioCryst Pharmaceuticals (BCRX.US)$ 0.0

Trytosaveabit

Jan 8 20:31

Update

$BioCryst Pharmaceuticals (BCRX.US)$ Reuters· 7 mins ago
BioCryst Pharmaceuticals Inc - Increases Wholesale Acquisition Cost for Orladeyo to $44,484.33 per 28-Day Pack